Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT03707509 · UNKNOWN
Trial details
- NCT number
- NCT03707509
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-13
- Primary completion
- 2021-08-01
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.